Submission Details
| 510(k) Number | K171338 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 08, 2017 |
| Decision Date | May 31, 2017 |
| Days to Decision | 23 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K171338 is an FDA 510(k) clearance for the B R A H M S PCT sensitive KRYPTOR, a Procalcitonin Assay (Class II — Special Controls, product code PRI), submitted by Brahms GmbH (Henningsdorf, DE). The FDA issued a Cleared decision on May 31, 2017, 23 days after receiving the submission on May 8, 2017. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3215.
| 510(k) Number | K171338 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 08, 2017 |
| Decision Date | May 31, 2017 |
| Days to Decision | 23 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | PRI — Procalcitonin Assay |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3215 |
| Definition | To Aid In Decision Making On Antibiotic Therapy, Including Antibiotic Initiation And Discontinuation, For Inpatients Or Patients In The Emergency Department, With Suspected Or Confirmed Lower Respiratory Tract Infections (lrti) Defined As Community-acquired Pneumonia (cap), Acute Bronchitis, And Acute Exacerbation Of Chronic Obstructive Pulmonary Disease (aecopd). |